David Y Liu Insider Profile
4 Followers
David Y Liu, Chief R&D Strategy Officer at Protagonist Therapeutics, holds 167.59K shares in Protagonist Therapeutics (Ticker: PTGX).
David Y Liu's Trading History
| PTGXProtagonist Therapeutics | Nov 17, 2022 | Chief R&D Strategy Officer | Uninformative Buy | 231.80K | $21.95M | |
PTGX Insider Shares: 167.59K (0.34%) David Y Liu has not reported any informative transactions for PTGX, therefore, performance cannot be measured. | ||||||
You May Also Like
David Y Liu insider profile FAQ
What stocks does David Y Liu hold?
David Y Liu holds: PTGX stocks.
What was David Y Liu’s latest transaction?
David Y Liu’s latest transaction was an Uninformative Buy of $231.80K.
What is David Y Liu's role in Protagonist Therapeutics?
David Y Liu's role in Protagonist Therapeutics is Chief R&D Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
